Capecitabine, Irinotecan, and Oxaliplatin in Treating Patients With Metastatic Cancer
Status:
Unknown status
Trial end date:
1969-12-31
Target enrollment:
Participant gender:
Summary
RATIONALE: Drugs used in chemotherapy, such as capecitabine, irinotecan, and oxaliplatin,
work in different ways to stop the growth of cancer cells, either by killing the cells or by
stopping them from dividing. Giving more than one drug (combination chemotherapy) may kill
more cancer cells.
PURPOSE: This phase I trial is studying the side effects and best dose of capecitabine when
given together with irinotecan and oxaliplatin in treating patients with metastatic cancer.